Cite
HARVARD Citation
Fontanella, C. et al. (2022). Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach. Critical reviews in oncology/hematology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fontanella, C. et al. (2022). Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer: A personalized approach. Critical reviews in oncology/hematology. p. . [Online].